论文部分内容阅读
抽取我院82例2型糖尿病随机分研究组和参照组各41例,参照组给予格列吡嗪缓释片和胰岛素治疗,观察组在此前提下加用重组甘精胰岛素治疗。结果:研究组的Hb A1c指标、FBG指标、PBG指标显著低于参照组,P<0.05;同时该组的低血糖发生率为7.3%较参照组的36.6%显著降低,P<0.05。结论:2型糖尿病经重组甘精胰岛素治疗,可快速控制血糖,降低低血糖发生概率。
A total of 82 patients with type 2 diabetes mellitus were randomized into study group and reference group, with 41 cases in each group. The reference group was treated with glipizide sustained-release tablets and insulin. The observation group was treated with recombinant insulin glargine on the premise. Results: The Hb A1c, FBG and PBG indexes of the study group were significantly lower than those of the reference group (P <0.05). The incidence of hypoglycemia in the study group was 7.3% lower than that of the reference group (36.6%, P <0.05). Conclusion: Type 2 diabetes treated with recombinant insulin glargine can rapidly control blood glucose and reduce the incidence of hypoglycemia.